Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

PHASE3CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

October 29, 2020

Primary Completion Date

August 9, 2023

Study Completion Date

August 9, 2023

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

MT-1186

Treatment cycles with daily dosing for 10 days out of a 14-day period, followed by a 14 day drug free period up to 96 weeks of treatment or until the drug is commercially available in that country.

Trial Locations (44)

10126

Universita degli Studi di Torino - Centro Regionale Esperto Per La Sclerosi Laterale Amiotrofica (CRESLA), Turin

15212

Alleghany General Hospital, Pittsburgh

17025

Penn State Hershey Children's Hospital, Hershey

20132

Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele), Milan

20162

Fondazione Serena Onlus - Azienda Ospedaliera Niguarda Ca Granda - Centro Clinico Nemo (Neuro Muscular Omnicentre), Milan

21209

Johns Hopkins University, Baltimore

27157

Wake Forest University Baptist Medical Center (WFUBMC) - The J. Paul Sticht Center on Aging and Rehabilitation, Winston-Salem

30625

Medizinische Hochschule Hannover, Hanover

33400

Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux

53226

Medical College of Wisconsin, Milwaukee

65191

Deutsche Klinik fuer Diagnostik, Wiesbaden

68506

Neurology Associates, P.C - Lincoln, Lincoln

72758

Woodland Research Northwest, Rogers

75013

Hopital Pierre Wertheimer - Hopital Neurologique, Paris

75214

Texas Neurology, PA, Dallas

80045

University of Colorado Anschutz Medical Campus, Aurora

85013

St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center, Phoenix

85028

Neuromuscular Research Center, Phoenix

87025

Centre Hospitalier Esquirol, Limoges

32610-3633

UF Health Cancer Center, Gainesville

30317-2819

Emory University - School of Medicine, Atlanta

T2N 4Z6

Heritage Medical Research Clinic - University Of Calgary, Calgary

T6G 2B7

University of Alberta - Walter C Mackenzie Health Sciences Centre (WCM), Edmonton

H3A 2B4

Montreal Neurological Institute and Hospital, Montreal

06001

CHU-Nice - Hopital Pasteur 2, Nice

480-1195

Aichi Medical University Hospital, Nagakute-shi

260-8712

National Hospital Organization Chibahigashi National Hospital, Chiba

819-8585

Murakami Karindoh Hospital, Fukuoka

960-1295

Fukushima Medical University Hospital, Fukushima

063-0005

National Hospital Organization Hokkaido Medical Center, Sapporo

920-0192

National Hospital Organization Iou National Hospital, Kanazawa

761-0793

Kagawa University Hospital, Kita-gun

252-0375

Kitasato University Hospital, Sagamihara

236-0004

Yokohama City University Hospital, Yokohama

861-1196

National Hospital Organization Kumamoto Saishun Medical Center, Koshi-shi

980-8574

Tohoku University Hospital, Sendai

951-8520

Niigata University Medical And Dental Hospital, Niigata

553-0003

Kansai Electric Power Hospital Recruiting, Fukushima-ku, Osaka-shi

560-8552

National Hospital Organization Toneyama Medical Center, Toyonaka-shi

520-2192

Shiga University of Medical Science Hospital, Ōtsu

420-8688

National Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka

113-8431

Juntendo University Hospital, Bunkyo-ku

183-0042

Tokyo Metropolitan Neurological Hospital, Fuchū

143-8541

Toho University Omori Medical Center, Ōta-ku

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma America Inc.

INDUSTRY